SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
209 hedge funds and large institutions have $798M invested in Sorrento Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 85 increasing their positions, 40 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
12% more funds holding
Funds holding: 186 → 209 (+23)
Holders
209
Holding in Top 10
2
Calls
$162M
Puts
$65.6M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$20.6M | |
| 3 | +$19.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$10.3M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$6.69M | |
| 3 | -$5.58M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.07M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.3M |